Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)

Q: What does CUSIP 501147102 represent in this 13F holders report?

CUSIP 501147102 is the security identifier for KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") used to aggregate holder disclosures.

Q: How many institutions held KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in Q3 2020?

98 institutional investors reported KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 501147102

Q3 2020 13F Holders as of 30 Sep 2020

Security type / class: Equity / Common Stock, $0.00001 par value ("Common Stock")
Total 13F shares: 14,383,109
Total 13F value: $619,123,442
Share change: +256,443
Put/Call ratio: 244%
SEC-reported price per share: $43.05
Number of holders: 98
Value change: +$11,279,105
Number of buys: 50
Number of sells: 45
Shares outstanding: 29,463,330

Security key

501147102

Report period

Q3 2020

Institutions

Top holders

KRYS full security history Ownership snapshot Full 13F holder table Krystal Biotech, Inc. SEC filings Krystal Biotech, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Redmile Group, LLC

Disclosed value leader

Redmile Group, LLC

Comparable rows

15/15

Latest evidence

30 Jun 2020

13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

Redmile Group, LLC leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Redmile Group, LLC's linked filing trail.

Comparable ownership Top 5

Redmile Group, LLC 4.8%

FMR LLC 4.5%

BlackRock Finance, Inc. 3.8%

PRICE T ROWE ASSOCIATES INC /MD/ 3.5%

FRAZIER MANAGEMENT LLC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Redmile Group, LLC	13F Company 13F	4.8%	$58,392,000 1,409,745 shares	—	30 Jun 2020
FMR LLC	13F Company 13F	4.5%	$55,059,000 1,329,286 shares	—	30 Jun 2020
BlackRock Finance, Inc.	13F Company 13F	3.8%	$45,933,000 1,108,984 shares	—	30 Jun 2020
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	3.5%	$42,348,000 1,022,415 shares	—	30 Jun 2020
FRAZIER MANAGEMENT LLC	13F Company 13F	3%	$37,071,000 895,000 shares	—	30 Jun 2020
BAKER BROS. ADVISORS LP	13F Company 13F	2.8%	$33,866,000 817,631 shares	—	30 Jun 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,383,109

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

108

Q3 2020 holders

Holder diff

-10

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 value	Q3 2020 value	Value change	Value Chg %